Free Trial
NASDAQ:KTTAW

Pasithea Therapeutics (KTTAW) Stock Price, News & Analysis

$0.02 +0.01 (+40.00%)
As of 07/8/2025 03:43 PM Eastern

About Pasithea Therapeutics Stock (NASDAQ:KTTAW)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.03
52-Week Range
$0.01
$0.10
Volume
1,000 shs
Average Volume
27,577 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive KTTAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

KTTAW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

KTTAW Stock Analysis - Frequently Asked Questions

Pasithea Therapeutics' stock was trading at $0.0346 on January 1st, 2025. Since then, KTTAW stock has decreased by 39.3% and is now trading at $0.0210.

Shares of KTTAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KTTAW
CIK
1841330
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:KTTAW) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners